Post-approval studies (Phase 4)UnknownNCT05916911
What this trial is testing
Evaluation Of The Efficacy Of The Combination Of GLIZIGEN® Oral Solution 1/Day And Vaginal Gel 1/Night For 2 Months In Patients With Cervical Intraepithelial Neoplasia Grade 1 (LSIL/CIN-1) Caused By High-Risk Human Papillomavirus (HPV-AR)
Who this might be right for
Papilloma Viral InfectionCIN1LSIL, Low Grade Squamous Intraepithelial Lesion
Catalysis SL 120